Stockreport

Inhibrx Biosciences Reports Third Quarter 2024 Financial Results [Yahoo! Finance]

Inhibrx Biosciences, Inc.  (INBX) 
PDF Following the completion of the sale of INBRX-101 by Inhibrx, Inc. (the "Former Parent") to Sanofi S.A. and the Former Parent's concurrent spin-off of the Inhibrx Biosci [Read more]